How I treat age-related morbidities in elderly persons with hemophilia
- 17 December 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 114 (26), 5256-5263
- https://doi.org/10.1182/blood-2009-07-215665
Abstract
In persons with hemophilia, life expectancy is now approaching that of the general male population, at least in countries that can afford regular replacement therapy with coagulation factor concentrates. The new challenges for comprehensive treatment centers are thus to provide optimal health care for this aging population of patients, who often present not only with the comorbidities typically associated with hemophilia (arthropathy, chronic pain, blood-borne infections), but also with common age-related illnesses such as cardiovascular disease and cancer. There are no evidence-based guidelines for the management of these conditions, which often require drugs that interfere with hemostasis, enhance the bleeding tendency, and warrant more intensive replacement therapy. At the moment, elderly patients with hemophilia affected by other diseases should be managed like their age-group peers without hemophilia, provided replacement therapy is tailored to the heightened risk of bleeding associated with the need for invasive procedures and drugs that further compromise the deranged hemostasis. More detailed advice is provided on the schedules of replacement therapy needed to tackle cardiovascular diseases, such as acute coronary syndromes and nonvalvular atrial fibrillation, because these conditions will become more and more frequent challenges for the comprehensive treatment centers.Keywords
This publication has 69 references indexed in Scilit:
- Emerging clinical concerns in the ageing haemophilia patientHaemophilia, 2009
- Factors influencing the long‐term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institutionBritish Journal of Haematology, 2009
- Prevalence and risk factors associated with decreased bone mineral density in patients with haemophiliaHaemophilia, 2009
- Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral TherapyCirculation, 2008
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled TrialsCirculation, 2008
- Experimental melanoma metastasis in lungs of mice with congenital coagulation disordersJournal of Cellular and Molecular Medicine, 2008
- Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-upBlood, 2006
- Inhibitors in mild/moderate haemophilia A: An updateThrombosis and Haemostasis, 2006
- Intracranial haemorrhages in French haemophilia patients (1991–2001): clinical presentation, management and prognosis factors for deathHaemophilia, 2005
- Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.BMJ, 1989